Leukämie hemmender Faktor

A leukaemia-inhibitory factor (LIF) is disclosed, together with a method of preparation of LIF in essentially pure form. Nucleotide and amino acid sequences are disclosed, together with recombinant DNA molecules and host cells for production of polypeptides having LIF activity.

Saved in:
Bibliographic Details
Main Authors SIMPSON, RICHARD JOHN, VICTORIA, AU, METCALF, DONALD, VICTORIA, AU, NICOLA, NICOS ANTHONY, VICTORIA, AU, NICE, EDOUARD COLLINS, VICTORIA, AU, GEARING, DAVID PAUL, VICTORIA, AU, WILLSON, TRACY ANN, VICTORIA, AU, HILTON, DOUGLAS JAMES, VICTORIA, AU, KING, JULIE ANN, VICTORIA, AU, GOUGH, NICHOLAS MARTIN, VICTORIA, AU
Format Patent
LanguageGerman
Published 28.07.1994
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A leukaemia-inhibitory factor (LIF) is disclosed, together with a method of preparation of LIF in essentially pure form. Nucleotide and amino acid sequences are disclosed, together with recombinant DNA molecules and host cells for production of polypeptides having LIF activity.
Bibliography:Application Number: DE19883888379T